Arne Mueller studied biology in Goettingen, Germany, and earned a PhD in structural bioinformatics at CRUK and UCL, London. He completed a Postdoc in toxicogenomics at Aventis Pharma, Paris, and worked in genomics and data science at Sanofi, Paris. In 2007, Arne joined Novartis in Basel, focusing on data science in preclinical safety. Since 2016, he has been involved in digital endpoint analytics at Novartis Biomedical Research, Basel. Arne has gained expertise in neuro-muscular and neuro-developmental disorders as well as in the cardiovascular field with a focus on mobility and motor function. He has been part of the leadership in the IMI Mobilise-D and SUSTAIN consortium.
